Glycolytic metabolism and tumour response to fractionated irradiation

References 

1. Rajendran JG, Mankoff DA, O’Sullivan F, et al. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res. 2004;7:2245–2252
2. Zu XL, Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun. 2004;3:459–465
3. Atsumi T, Chesney J, Metz C, et al. High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res. 2002;20:5881–5887
4. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004;11:891–899
5. Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002;4:S62–S67
6. Warburg O. Origin of cancer cells. Science. 1956;3191:309–314
7. Schwickert G, Walenta S, Sundfor K, Rofstad EK, Mueller-Klieser W. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res. 1995;21:4757–4759
8. Walenta S, Salameh A, Lyng H, et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol. 1997;2:409–415
9. Brizel DM, Schroeder T, Scher RL, et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;2:349–353
10. Walenta S, Wetterling M, Lehrke M, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;4:916–921
11. Groussard C, Morel I, Chevanne M, et al. Free radical scavenging and antioxidant effects of lactate ion: an in vitro study. J Appl Physiol. 2000;1:169–175
12. Salahudeen AK, Clark EC, Nath KA. Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo. J Clin Invest. 1991;6:1886–1893
13. Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004;6:437–447
    • MEDLINE
14. Quennet V, Yaromina A, Zips D, et al. Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice. Radiother Oncol. 2006;2:130–135
15. Yaromina A, Zips D, Thames HD, et al. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies. Radiother Oncol. 2006;2:122–129
16. Yaromina A, Krause M, Thames H, et al. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiother Oncol. 2007;3:304–310
17. Yaromina A, Holscher T, Eicheler W, et al. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?. Radiother Oncol. 2005;2:206–212
18. Bayer C, Schilling D, Hoetzel J, et al. PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck. Radiother Oncol. 2008;3:361–368
19. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer. 2008;7:545–554
    • MEDLINE
20. Mueller-Klieser W, Walenta S. Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging. Histochem J. 1993;6:407–420
21. Sattler UG, Walenta S, Mueller-Klieser W. A bioluminescence technique for quantitative and structure-associated imaging of pyruvate. Lab Invest. 2007;1:84–92
22. Lallemant B, Evrard A, Combescure C, et al. Reference gene selection for head and neck squamous cell carcinoma gene expression studies. BMC Mol Biol. 2009;1:78
23. Yaromina A, Eckardt A, Zips D, et al. Core needle biopsies for determination of the microenvironment in individual tumours for longitudinal radiobiological studies. Radiother Oncol. 2009;3:460–465
24. Walenta S, Chau T-V, Schroeder T, et al. Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists?. J Cancer Res Clin Oncol. 2003;6:321–326
25. Walenta S, Mueller-Klieser WF. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol. 2004;3:267–274
26. Walenta S, Schroeder T, Mueller-Klieser W. Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem. 2004;16:2195–2204
27. Grotius J, Dittfeld C, Huether M, et al. Impact of exogenous lactate on survival and radioresponse of carcinoma cells in vitro. Int J Radiat Biol. 2009;11:989–1001
28. Cuezva JM, Ortega AD, Willers I, et al. The tumor suppressor function of mitochondria: translation into the clinics. Biochim Biophys Acta. 2009;
29. Melkus G, Morchel P, Behr VC, et al. Short-echo spectroscopic imaging combined with lactate editing in a single scan. NMR Biomed. 2008;10:1076–1086
30. Brindle K. New approaches for imaging tumour responses to treatment. Nat Rev Cancer. 2008;2:94–107
31. Plathow C, Weber WA. Tumor cell metabolism imaging. J Nucl Med. 2008;43S–63S
32. Laprie A, Pirzkall A, Haas-Kogan DA, et al. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2005;1:20–31
33. Raizer JJ, Koutcher JA, Abrey LE, et al. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. J Neurooncol. 2005;2:173–180
34. Xu M, See SJ, Ng WH, et al. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery. 2005;5:919–926
35. DeBerardinis RJ, Sayed N, Ditsworth D, Thompson CB. Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev. 2008;1:54–61
    • MEDLINE
    • CrossRef
36. Yaromina A, Quennet V, Zips D, et al. Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts. Int J Radiat Biol. 2009;11:972–980
37. Haji-Michael PG, Ladriere L, Sener A, Vincent JL, Malaisse WJ. Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood. Metab Clin Exp. 1999;6:779–785